Fred C. Krebs

2.4k total citations
76 papers, 1.9k citations indexed

About

Fred C. Krebs is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Fred C. Krebs has authored 76 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Virology, 30 papers in Infectious Diseases and 22 papers in Immunology. Recurrent topics in Fred C. Krebs's work include HIV Research and Treatment (42 papers), HIV/AIDS drug development and treatment (16 papers) and HIV/AIDS Research and Interventions (16 papers). Fred C. Krebs is often cited by papers focused on HIV Research and Treatment (42 papers), HIV/AIDS drug development and treatment (16 papers) and HIV/AIDS Research and Interventions (16 papers). Fred C. Krebs collaborates with scholars based in United States, Germany and France. Fred C. Krebs's co-authors include Brian Wigdahl, Vanessa Pirrone, Mary K. Howett, Shendra R. Miller, Daniel Malamud, Bradley J. Catalone, Mohamed E. Labib, Robert F. Rando, Vandana Miller and Michael R. Nonnemacher and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Virology.

In The Last Decade

Fred C. Krebs

75 papers receiving 1.8k citations

Peers

Countries citing papers authored by Fred C. Krebs

Since Specialization

Citations

This map shows the geographic impact of Fred C. Krebs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred C. Krebs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred C. Krebs more than expected).

Fields of papers citing papers by Fred C. Krebs

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred C. Krebs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred C. Krebs. The network helps show where Fred C. Krebs may publish in the future.

Co-authorship network of co-authors of Fred C. Krebs

This figure shows the co-authorship network connecting the top 25 collaborators of Fred C. Krebs. A scholar is included among the top collaborators of Fred C. Krebs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred C. Krebs. Fred C. Krebs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Electrochemical sensors for in situ monitoring of reactive species during cold atmospheric plasma-based therapies 2025 ·Communications Engineering ·(unknown), Suneel Kumar, (unknown), (unknown), (unknown), (unknown), (unknown), Madhavan Shanmugavel, Fred C. Krebs, François Berthiaume, Vandana Miller, Katharina Stapelmann	0
2	Immunological Control of Herpes Simplex Virus Type 1 Infection: A Non-Thermal Plasma-Based Approach 2025 ·Viruses ·(unknown), Jennifer L. Hope, Brian Wigdahl, Vandana Miller, Fred C. Krebs	1
3	Non-Thermal Plasma Reduces HSV-1 Infection of and Replication in HaCaT Keratinocytes In Vitro 2024 ·International Journal of Molecular Sciences ·(unknown), (unknown), Brian Wigdahl, Peter Bruggeman, Fred C. Krebs, Vandana Miller	5
4	By Any Other Name: Searching for the Right Plasma Nomenclature 2024 ·IEEE Transactions on Radiation and Plasma Medical Sciences ·(unknown), Rachel Bennett, Vandana Miller, Fred C. Krebs, Will Dampier	1
5	Manipulation of Oxidative Stress Responses by Non-Thermal Plasma to Treat Herpes Simplex Virus Type 1 Infection and Disease 2023 ·International Journal of Molecular Sciences ·(unknown), Peter Bruggeman, Brian Wigdahl, Fred C. Krebs, Vandana Miller	14
6	Inclusion of Biological Targets in the Analysis of Electrical Characteristics of Non-Thermal Plasma Discharge 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), Fred C. Krebs, Sophia Gershman, Vandana Miller	6
7	Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection 2021 ·PLoS ONE ·(unknown), Ramona Clemen, Eric Freund, Jan‐Wilm Lackmann, Kristian Wende, Jennifer Connors, Elias K. Haddad, Will Dampier, Brian Wigdahl, Vandana Miller, Sander Bekeschus, Fred C. Krebs	16
8	The Evolution of Dendritic Cell Immunotherapy against HIV‐1 Infection: Improvements and Outlook 2020 ·Journal of Immunology Research ·(unknown), Vandana Miller, Stephen R. Jennings, Brian Wigdahl, Fred C. Krebs	9
9	Non-thermal plasma-induced immunogenic cell death in cancer 2019 ·Journal of Physics D Applied Physics ·(unknown), (unknown), Abraham Lin, Fred C. Krebs, Adam E. Snook, Sander Bekeschus, Wilbur B. Bowne, Vandana Miller	75
10	Variability in human semen content and its potential effects in the female reproductive tract 2016 ·(unknown), (unknown), Brian Wigdahl, Fred C. Krebs	1
11	Utilization of HIV-1 envelope V3 to identify X4- and R5-specific Tat and LTR sequence signatures 2016 ·Retrovirology ·Gregory C. Antell, Will Dampier, Benjamas Aiamkitsumrit, Michael R. Nonnemacher, Jeffrey M. Jacobson, Vanessa Pirrone, (unknown), (unknown), Shendra Passic, (unknown), Gregory W. Schwartz, Uri Hershberg, Fred C. Krebs, Brian Wigdahl	15
12	Critical Review 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·(unknown), (unknown), Brian Wigdahl, Fred C. Krebs	11
13	Application and removal of polyanionic microbicide compounds enhances subsequent infection by HIV-1 2012 ·Virology Journal ·Vanessa Pirrone, Shendra Passic, Brian Wigdahl, Fred C. Krebs	13
14	Cervicovaginal Safety of the Formulated, Biguanide‐Based Human Immunodeficiency Virus Type 1 (HIV‐1) Inhibitor NB325 in a Murine Model 2011 ·BioMed Research International ·(unknown), Tina Kish-Catalone, Vanessa Pirrone, Robert F. Rando, Mohamed E. Labib, Brian Wigdahl, Fred C. Krebs	3
15	Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1 2010 ·Virology ·(unknown), Lindsay Wieczorek, (unknown), Alan J. Benesi, Bruce K. Brown, (unknown), Fred C. Krebs, Brian Wigdahl, Robert Blumenthal, Anu Puri, Francine E. McCutchan, Deborah L. Birx, Victoria R. Polonis, Cara‐Lynne Schengrund	30
16	Prolonged exposure to the candidate microbicide C31G differentially reduces cellular sensitivity to agent re-exposure 2005 ·Biomedicine & Pharmacotherapy ·Bradley J. Catalone, Mary Ferguson, Shendra R. Miller, Daniel Malamud, Tina Kish-Catalone, (unknown), Fred C. Krebs, Mary K. Howett, Brian Wigdahl	8
17	Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G 2005 ·Biomedicine & Pharmacotherapy ·Bradley J. Catalone, Shendra R. Miller, Mary Ferguson, Daniel Malamud, Tina Kish-Catalone, (unknown), Fred C. Krebs, Mary K. Howett, Brian Wigdahl	14
18	High-Affinity Interaction between HIV-1 Vpr and Specific Sequences That Span the C/EBP and Adjacent NF- κ B Sites within the HIV-1 LTR Correlate with HIV-1-Associated Dementia 2004 ·DNA and Cell Biology ·Tricia H. Burdo, Michael R. Nonnemacher, (unknown), Catherine H. Choi, Fred C. Krebs, Suzanne Gartner, Brian Wigdahl	32
19	Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate 1999 ·Antiviral Research ·Fred C. Krebs, Shendra R. Miller, Daniel Malamud, Mary K. Howett, Brian Wigdahl	92
20	Spl and related factors fail to interact with the NF-kB-proximal G/C box in the LTR of a replication competent, brain-derived strain of HIV-1 (YU-2) 1998 ·Journal of NeuroVirology ·Scott Millhouse, Fred C. Krebs, Jing Yao, (unknown), Joe Conner, (unknown), Brian Wigdahl	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact